leisure time -WSS

leisure time

author：explore 2025-10-02 21:35:34 - browse：817

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Ethical issues complicate the benefits of medical crowdfunding

Wikipedia

WSS

Weighted lottery helped low

Woman returns to dialysis after doctors remove transplanted pig kidney

See how much Covid

BMI, flaws aside, is found to be useful estimate of body fat in youth

ASCO: Palliative care found as helpful given virtually as in person

NIH nominee Bertagnolli will get October confirmation hearing

leisure time

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

At ASCO, AstraZeneca reports strong data for breast cancer drug

New air purifier tech could be key to improving indoor air quality

Trump surgeon general acknowledges mistakes during Covid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Change Healthcare can notify patients about the breach, HHS says

The high cost of giving birth even with insurance

A new House health package & hospitals’ new site

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

leisure time

FDA's Pazdur wants cancer trials to range beyond China alone

Medicaid rebukes states for mistakenly disenrolling children

Why Novartis is changing the name of its research labs

What drug price negotiations mean for Medicare Part D

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

How to increase colonoscopy rates? Looks like an AI can help

explore

entertainment

Wikipedia

Wikipedia